Tanja Lahaye

2.3k citations
22 papers · 1.4k indexed · 1 hit paper · h-index 12
Topics
Chronic Myeloid Leukemia Treatments (20 papers)Chronic Lymphocytic Leukemia Research (16 papers)Eosinophilic Disorders and Syndromes (10 papers)

In The Last Decade

Tanja Lahaye

20 papers receiving 1.4k citations

Hit Papers

Molecular and chromosomal mechanisms of resistance to ima...20022026201020182002200400600

Peers

Tanja Lahaye
Comparison fields: 5 of 58
  • Hematology 1.2k
  • Genetics 1.0k
  • Rheumatology 762
  • Molecular Biology 174
  • Oncology 141
Replace Manuel Ayala with:
Manuel Ayala Mexico
Benjamin Hanfstein Germany
Gabriele Gugliotta Italy
Franck E. Nicolini France
Melissa Holtz United States
Niove E. Jordanides United Kingdom
J. Chabrol France
Jean-Luc Laı̈ France
J V Melo United Kingdom
F-X Mahon France
Tanja Lahaye relative to Manuel Ayala Mexico Manuel Ayala's profile →
Citations per field
00.5×1.7×
Manuel Ayala · 1×
Citations per year

Countries citing papers authored by Tanja Lahaye

Since Specialization
Citations

This map shows the geographic impact of Tanja Lahaye's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tanja Lahaye with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tanja Lahaye more than expected).

Fields of papers citing papers by Tanja Lahaye

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tanja Lahaye. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tanja Lahaye. The network helps show where Tanja Lahaye may publish in the future.

Co-authorship network of co-authors of Tanja Lahaye

This figure shows the co-authorship network connecting the top 25 collaborators of Tanja Lahaye. A scholar is included among the top collaborators of Tanja Lahaye based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tanja Lahaye. Tanja Lahaye is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 29
2 2
3 1
4 4
5 10
6 54
7 191
8 6
9 1
10 23
11 65
12 17
13 49
14
Molecular and chromosomal mechanisms of resistance to imatinib (STI571) therapybreakdown →
675
15 26
16 124
17
[Systemic infections of dental origin].
5
18 109
19
Molecular and chromosomal mechanisms of resistance in CML patients after STI571 (Glivec) therapy
16
20
[Unusual cause of hyponatremia].
1

About Tanja Lahaye

Tanja Lahaye is a scholar working on Hematology, Genetics and Rheumatology, having authored 22 papers that have together received 1.4k indexed citations. Recurring topics across this work include Chronic Myeloid Leukemia Treatments (20 papers), Chronic Lymphocytic Leukemia Research (16 papers) and Eosinophilic Disorders and Syndromes (10 papers). The work is most often cited by research in Hematology (1.2k citations), Genetics (1.0k citations) and Rheumatology (762 citations). Tanja Lahaye has collaborated with scholars based in Germany, United States and Switzerland. Frequent co-authors include Andreas Hochhaus, Rüdiger Hehlmann, Sebastian Kreil, Claudia Schoch, Ute Berger, Harald Gschaidmeier, Paul La Rosée, A. Corbin, Brian Druker and Nicholas C.P. Cross. Their work appears in journals such as Blood, Cancer and Annals of the New York Academy of Sciences.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026